Northwestern University Human Resources
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-28
- Employees
- 5K
- Market Cap
- -
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Not Applicable
Completed
- Conditions
- SchizophreniaSchizoaffective DisorderBipolar Disorder
- Interventions
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2019-08-06
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 49
- Registration Number
- NCT00288366
- Locations
- 🇺🇸
Psychiatric Hospital at Vanderbilt, Nashville, Tennessee, United States
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Phase 3
Terminated
- Conditions
- SchizophreniaSchizoaffective DisorderBipolar Disorder
- Interventions
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 250
- Registration Number
- NCT00288353
- Locations
- 🇺🇸
Vanderbilt Psychiatric Hospital, Nashville, Tennessee, United States
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
Phase 1
Terminated
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: Hematopoietic Stem Cell TransplantationDrug: GCSFDrug: Cyclosporins
- First Posted Date
- 2006-01-26
- Last Posted Date
- 2018-07-30
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 4
- Registration Number
- NCT00282412
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
Phase 1
Terminated
- Conditions
- Sarcoidosis
- Interventions
- Biological: Autologous hematopoietic stem cell transplantationBiological: Allogeneic stem cell transplantation
- First Posted Date
- 2006-01-26
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 2
- Registration Number
- NCT00282438
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer
Phase 1
Terminated
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2011-08-26
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 19
- Registration Number
- NCT00281996
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.
Completed
- Conditions
- Obesity
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2011-12-20
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 43
- Registration Number
- NCT00280527
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis
Phase 1
Terminated
- Conditions
- Multiple Sclerosis
- Interventions
- Biological: Hematopoietic stem cell transplantation
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 21
- Registration Number
- NCT00278655
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
Phase 2
Completed
- Conditions
- SYSTEMIC SCLERODERMA
- Interventions
- Procedure: stem cell transplantationDrug: standard of care
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2014-04-30
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 19
- Registration Number
- NCT00278525
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus
Phase 2
Completed
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- Biological: Hematopoietic stem cell transplantation
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2020-02-28
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 32
- Registration Number
- NCT00278538
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
Phase 1
Terminated
- Conditions
- MYOPATHY
- Interventions
- Biological: Hematopoietic stem cell transplantationDrug: ATG(rabbit)
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 7
- Registration Number
- NCT00278564
- Locations
- 🇺🇸
Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath